CC
PACB icon

Centiva Capital’s Pacific Biosciences PACB Stock Holding History

Centiva Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,358
Closed -$39.7K – 2231
2024
Q3 		$39.7K Buy
+23,358
New +$38.4K ﹤0.01% 2011
2024
Q1 		– Sell
-18,520
Closed -$182K – 2151
2023
Q4 		$182K Buy
+18,520
New +$151K 0.01% 1457
2022
Q4 		– Sell
-71,191
Closed -$414K – 1594
2022
Q3 		$414K Buy
+71,191
New +$408K 0.03% 937
2021
Q3 		– Sell
-8,736
Closed -$305K – 1544
2021
Q2 		$305K Buy
+8,736
New +$254K 0.02% 1034
2020
Q1 		– Sell
-75,000
Closed -$386K – 857
2019
Q4 		$386K Buy
+75,000
New +$381K 0.07% 503

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return